Estudo randomizado | Inibição de miosina em pacientes com cardiomiopatia hipertrófica obstrutiva encaminhados para terapia de redução de septo.

Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy – Journal of the American College of Cardiology

Conteúdo relacionado: #ACC22 [Not published yet] – RCT: Mavacamten reduces the need for surgical intervention in patients with obstructive hypertrophic cardiomyopathy.